White Paper

New Product Alert - Ruxolitinib & Salts

Ruxolitinib falls under the drug class known as Janus kinase inhibitors (JAK inhibitors). It is an inhibitor of the JAK1 and JAK2 protein kinases and works by competitively inhibiting the ATP-binding catalytic site on JAK1 and JAK2.

Our Offerings*:

Offers Ruxolitinib Phosphate (anhydrous crystalline form), Hemifumarate (Alternative salts) and Free Base APIs to meet formulation needs across various global markets.
As an early mover in API development, we have filed USDMF for Ruxolitinib Base & Ruxolitinib Hemifumarate Ruxolitinib Phosphate
Alternate salt provides early launch opportunities in Europe, Canada, Mexico, Malaysia, South Africa, Turkey, and South Korea.
Quality as per ICH guidelines
Customised particle size distribution (PSD) can be provided based on customer needs.

To learn more about our API offerings, please read the Product alert on Ruxolitinib Phosphate by filling out the contact form below.

Explore other Whitepapers:

Know More

Email us: api@drreddys.com
+91 40 49002222

Download Now

Please fill the Contact form below in order to view the white paper

* I agree and accept the Privacy Policy and Terms of Use of this website.

Email us: api@drreddys.com | +91 40 49002222

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.